Study S001208

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05933499
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 63
Start: 2025-11-05
Primary completion: 2028-12-31
Lead sponsor: Massachusetts General Hospital
Conditions: Obesity
Interventions: DRUG:Bimagrumab; DRUG:Tirzepatide; DIETARY_SUPPLEMENT:Calcium/Vitamin D; BEHAVIORAL:Lifestyle and nutrition counseling
Results posted: FALSE

Registered primary outcomes

Change in number of kilograms of lean mass by dual-energy x-ray absorptiometry [52 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.